Hawk Biosystems is proud to announce our participation as a Gold Sponsor at Multi-Omics 2024, a pivotal event in Brisbane, Australia, dedicated to the rapidly expanding field of multi-omics. Taking place over three days, this event will spotlight groundbreaking developments in Spatial Biology, Digital Pathology, Artificial Intelligence, and omics-based deep tissue and liquid biopsy profiling. Hawk Biosystems is excited to contribute to the discussions and innovation at this meeting. Our CEO Fernando Aguirre, COO Juan Gumuzio, and Product Manager James Miles will be attending, with James Miles delivering a short talk to share our latest advancements.
As part of our gold sponsorship, James Miles will deliver a short talk during the event, focusing on how Hawk Biosystems is integrating multi-omics with spatial biology to enhance disease profiling and therapeutic response prediction. With our innovative QF-Pro® platform, we are advancing the ability to spatially quantify protein functions and interactions within the tumour microenvironment. This data-driven approach is proving invaluable in areas such as immuno-oncology, where precise molecular interactions are key to understanding patient responses to therapies. We look forward to showcasing how Hawk Biosystems is leveraging multi-omics technologies to improve clinical outcomes.
Multi-Omics 2024 aims to bring together a diverse range of researchers from around the world to explore how multi-omics is transforming our understanding of disease biology. With applications spanning cancer, infectious disease, and immunology, the event will feature thought-provoking sessions on experimental design, methodologies, and analytical pipelines, including bioinformatics and computational biology. The conference offers a dynamic mix of presentations from leading experts, alongside platform launches, technical workshops, and analysis of real-world datasets. This convergence of technology and science promises to drive forward the future of healthcare.
This project has been co-funded by the European Union’s Horizon Europe research and innovation programme under grant agreement Nº101161495.
“Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.”
Stay connected
Subscribe to the HAWK Biosystems newsletter and don’t miss any news about our company, our products, events and much more.